InsiderTrades

Form 4 for WEX WEX Inc.

Accepted 2023-07-17 00:00:00 ET · period of report 2023-07-13 · accession 0001309108-23-000158 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-17 2023-07-13 WEX Smith Melissa D COB, CEO, Pres, Dir M - OptEx $99.69 +41.1K 123.1K +50% +$4.10M
D 2023-07-17 2023-07-13 WEX Smith Melissa D COB, CEO, Pres, Dir S - Sale+OE $195.00 -41.1K 82.0K -33% -$8.02M
D 2023-07-17 2023-07-13 WEX Smith Melissa D COB, CEO, Pres, Dir M - OptEx $0.00 -41.1K 46.0K -47% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-07-13 M A 41,107 $99.69 123,105 D — —
2 Common Common Stock 2023-07-13 S D 41,107 $195.00 81,998 D — — (F1) The reported exercising of 41,107 options and subsequent sale of 41,107 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023.
3 Derivative Stock Option (right to buy) 2023-07-13 M D 41,107 $0.00 46,029 D $99.69 · — to 2027-05-10 41,107 Common Stock (F3) Half of the performance-based non-statutory stock options ("Performance-Based NSOs"), reported on the Reporting Person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.